tisagenlecleucel,ibrutinib,bendamustine
Bayer,janssen,roche,novartis,teva,abbvie
['mantle,(-dismantle)', 'tisagenlecleucel', 'fludarabine', 'bendamustine', ' ibru', 'cyclophosphamide', 'tisa-cel', 'ritux', 'lymphoma', 'lymsm', 'imab ']
really exciting concept: tisa-cel + time-limited ibrutinib in r/r mantle cell lymphoma. mostly high-risk, btk exposed. 44% tp53mut. orr 80%. median pfs nr at 13 mos. worse outcomes with benda pretx (known problem), tp53 outcomes just as good. #ash22 #lymsm 
#lymsm & #mmsm hematologist & patient-reported outcomes researcher @CUHematology. Founder of https://t.co/kN6qeGXfg5, @inTrainingDoc & @inHouseMag. ??????